| Tender Details | ||||||||
                    
  | 
            ||||||||
| Deadline * | ||||||||
                        
  | 
                ||||||||
| Client Address | ||||||||
                        
  | 
                ||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 8259327
 - Location: Germany
 
Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1
- Deadline: 10 May 2026
 
- Ref No: 8260726
 - Location: Germany
 
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg
- Deadline: 10 May 2026
 
- Ref No: 5301821
 - Location: Bulgaria
 
Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad
- Deadline: 27 May 2027
 
- Ref No: 5332318
 - Location: Germany
 
Dynamic Procurement System Dbs For Green Electricity Deliveries From 2025 For The City Of Wolfsburg
- Deadline: 23 Apr 2026
 
- Ref No: 5396790
 - Location: Germany
 
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L
- Deadline: 27 Apr 2026
 
- Ref No: 4641976
 - Location: Germany
 
Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55
- Deadline: 28 Feb 2026
 
- Ref No: 3133479
 - Location: Israel
 
Requests For Financial Participation Of The Ministry Of Energy In Conferences Seminars And Exhibitions
- Deadline: 31 Dec 2029
 
- Ref No: 4638957
 - Location: Germany
 
Medicines With The Active Ingredient Tacrolimus Atc L04Ad02
- Deadline: 28 Feb 2026
 
- Ref No: 5226107
 - Location: Germany
 
Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08
- Deadline: 31 Mar 2026
 
- Ref No: 5976401
 - Location: Germany
 
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf
- Deadline: 10 May 2026
 
- Ref No: 5965319
 - Location: Germany
 
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medi
- Deadline: 10 May 2026
 
- Ref No: 5968352
 - Location: Germany
 
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage
- Deadline: 10 May 2026
 
- Ref No: 5969462
 - Location: Germany
 
Dynamic Procurement System Dbs For Green Electricity Supplies From 2025 For The City Of Wolfsburg
- Deadline: 23 Apr 2026